DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cbfv9c/dendritic_cell) has announced the addition of the "Dendritic Cell Cancer Vaccine Market & Clinical Insight" report to their offering.
The high pace of research and development along with initial positive results in experimental studies is expected to create large market for dendritic cell based cancer vaccines.
The design of dendritic cell cancer vaccine is likely to improve and much emphasis will be on multiple cancer antigen targeting capabilities of a single molecule. Computer technology is helping oncologists to design and run simulations on these hypothetical vaccines to check their effect on cellular machinery even before going to laboratory and consuming precious resources. This technology could also save lots of time by performing analysis on hundreds of probable vaccine candidates in single experiment. However, the results of such dendritic cell cancer vaccines remain elusive in clinical trials which may be marketed if they produce the significant pharmacological effects in eradicating the cancer.
Dendritic Cell Vaccine Market & Clinical Insight Report Highlights:
- Dendritic Cell Cancer Vaccine in Clinical Pipeline: 52
- Majority of Dendritic Cell Cancer Vaccine in Phase-II: 13
- Marketed Dendritic Cell Cancer Vaccine: 3 (CreaVax, Provenge & DC-CIK)
Key Topics Covered:
1. Introduction to Dendritic Cell Cancer Vaccines
2. Mechanism of Dendritic Cell Cancer Vaccine
3. Dendritic Cell Cancer Vaccine Market Overview
4. Dendritic Cell Cancer Vaccine Market Dynamics
5. Dendritic Cell Cancer Vaccine Future Prospects
6. Dendritic Cell Cancer Vaccine Clinical Insight by Phase, Indication & Company
7. Marketed Dendritic Cell Cancer Vaccine Clinical Insight
8. Suspended & Discontinued Clinical Trials Insight
9. Competitive Landscape
- 3M Company
- Activartis
- Batavia Bioservices
- Creagene
- Dendreon
- Merck
- Northwest Biotherapeutics
- Glaxo Smith Kline
- ImmunoCellular Therapeutics
- Tella Incorporation
For more information visit http://www.researchandmarkets.com/research/cbfv9c/dendritic_cell
